DBPR108: Clinical Trials

1 trial of DBPR108, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow DBPR108: new trials by email Literature Review of DBPR108 trials Research Report on DBPR108

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
DBPR108 tablet(50mg), Placebo matching DBPR108 tablet(100mg), DBPR108 tablet(100mg), Placebo matching DBPR108 tablet(50mg), Placebo matching DBPR108 tablet(100mg), DBPR108 tablet(100mg), Placebo matching DBPR108 tablet(50mg) - Type 2 Diabetes Mellitus
Phase 2CompletedCSPC ZhongQi Pharmaceutical Technology Co., Ltd.2762017-10-172019-10-15

Conditions studied

Diabetes Mellitus, Type 2 (1)

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)

Countries

China (1)

Results publications

PMID 32338063